Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v7-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2019-08-17 | 2019-07-26 |
| Drug Identification Number | 02139537 | 02139537 |
| Brand name | PROTAMINE SULFATE INJECTION, USP | PROTAMINE SULFATE INJECTION, USP |
| Common or Proper name | Protamine Sulfate | Protamine Sulfate |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | PROTAMINE SULFATE | PROTAMINE SULFATE |
| Strength(s) | 10MG | 10MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS | INTRAVENOUS |
| Packaging size | 25mL | 25mL |
| ATC code | V03AB | V03AB |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2019-07-26 | 2019-07-26 |
| Estimated end date | 2019-08-16 | 2019-08-16 |
| Actual end date | 2019-08-16 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Sandoz Canada Inc. is the alternate supplier of Protamine SO4 Inj 10mg/mL 25mLVial in the market. They have been informed of our backorder and have confirmed their ability to cover Fresenius Kabi Canada’s customers during the product shortage. | |
| Health Canada comments |